糖尿病網膜症治療の世界市場:疫学予測

◆英語タイトル:Diabetic Retinopathy - Epidemiology Forecast To 2023
◆商品コード:DLVE704023
◆発行会社(リサーチ会社):DelveInsight
◆発行日:2017年3月
◆ページ数:45
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2営業日以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,750 ⇒換算¥305,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD5,500 ⇒換算¥610,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD8,250 ⇒換算¥915,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

DelveInsight’s Diabetic Retinopathy – Epidemiology Forecast to 2023 Report provides an overview of the epidemiology trends of Diabetic Retinopathy in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Diabetic Retinopathy prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Diabetic Retinopathy. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts. Key Coverage and Benefits:
• The report will help in developing business strategies by understanding the trends shaping and driving the global Diabetic Retinopathy market.
• Identifying prevalent patient populations as well as risk factors in the global Diabetic retinopathy market will help to improve product design, pricing, and launch plans.
• Organize marketing efforts by identifying the best opportunities for Diabetic retinopathy therapeutics in each of the markets covered.

【レポートの目次】

Report Introduction
Diabetic Retinopathy: Overview
Stages
Symptoms
Types
Pathophysiology
Etiology
Risk Factors
Disease Burden
Unmet Needs
Epidemiology of Diabetic Retinopathy in 7MM
United States
Sex Specific Prevalence of Diabetes Retinopathy in US
Age- Specific Prevalence of Diabetes Retinopathy in US
Sub-type Prevalence of Diabetes Retinopathy in US
EU5
United Kingdom
Sex Specific Prevalence of Diabetes Retinopathy in UK
Age- Specific Prevalence of Diabetes Retinopathy in UK
Sub-type Prevalence of Diabetes Retinopathy in UK
France
Sex Specific Prevalence of Diabetes Retinopathy in France
Age- Specific Prevalence of Diabetes Retinopathy in France
Sub-type Prevalence of Diabetes Retinopathy in France
Italy
Sex Specific Prevalence of Diabetes Retinopathy in Italy
Age- Specific Prevalence of Diabetes Retinopathy in Italy
Sub-type Prevalence of Diabetes Retinopathy in Italy
Germany
Sex Specific Prevalence of Diabetes Retinopathy in Germany
Age- Specific Prevalence of Diabetes Retinopathy in Germany
Sub-type Prevalence of Diabetes Retinopathy in Germany
Spain
Sex Specific Prevalence of Diabetes Retinopathy in Spain
Age- Specific Prevalence of Diabetes Retinopathy in Spain
Sub-type Prevalence of Diabetes Retinopathy in Spain
Japan
Sex Specific Prevalence of Diabetes Retinopathy in Japan
Age- Specific Prevalence of Diabetes Retinopathy in Japan
Sub-type Prevalence of Diabetes Retinopathy in Japan
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

Table 1: Prevalent Population of Diabetic Retinopathy in United States (2013-2023)
Table 2: Sex Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Table 3: Age-Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Table 4: Sub-type Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Table 5: Prevalent Population of Diabetic Retinopathy in United Kingdom (2013-2023)
Table 6: Sex Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Table 7: Age-Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Table 8: Sub-type Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Table 9: Prevalent Population of Diabetic Retinopathy in France (2013-2023)
Table 10: Sex Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Table 11: Age-Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Table 12: Sub-type Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Table 13: Prevalent Population of Diabetic Retinopathy in Italy (2013-2023)
Table 14: Sex Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Table 15: Age-Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Table 16: Sub-type Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Table 17: Prevalent Population of Diabetic Retinopathy in Germany (2013-2023)
Table 18: Sex Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Table 19: Age-Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Table 20: Sub-type Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Table 21: Prevalent Population of Diabetic Retinopathy in Spain (2013-2023)
Table 22: Sex Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Table 23: Age-Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Table 24: Sub-type Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Table 25: Prevalent Population of Diabetic Retinopathy in Japan (2013-2023)
Table 26: Sex Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
Table 27: Age-Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
Table 28: Sub-type Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)


Figure 1: Risk Factors of Diabetic Retinopathy
Figure 2: Prevalent Population of Diabetic Retinopathy in United States (2013-2023)
Figure 3: Sex Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Figure 4: Age-Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Figure 5: Sub-type Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
Figure 6: Prevalent Population of Diabetes Retinopathy in United Kingdom (2013-2023)
Figure 7: Sex Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Figure 8: Age- Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Figure 9: Sub-type Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
Figure 10: Prevalent Population of Diabetic Retinopathy in France (2013-2023)
Figure 11: Sex Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Figure 12: Age- Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Figure 13: Sub-type Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
Figure 14: Prevalent Population of Diabetic Retinopathy in Italy (2013-2023)
Figure 15: Sex Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Figure 16: Age-Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Figure 17: Sub-type Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
Figure 18: Prevalent Population of Diabetic Retinopathy in Germany (2013-2023)
Figure 19: Sex Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Figure 20: Age- Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Figure 21: Sub-type Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
Figure 22: Prevalent Population of Diabetic Retinopathy Spain (2013-2023)
Figure 23: Sex Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Figure 24: Age- Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Figure 25: Sub-type Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
Figure 26: Prevalent Population of Diabetic Retinopathy in Japan (2013-2023)
Figure 27: Sex Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
Figure 28: Age-Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
Figure 29: Sub-type Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 糖尿病網膜症治療の世界市場:疫学予測(Diabetic Retinopathy - Epidemiology Forecast To 2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆